Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Zynex, Inc. (ZYXI)

10.5   -0.255 (-2.37%) 03-17 16:00
Open: 10.69 Pre. Close: 10.755
High: 10.875 Low: 10.42
Volume: 373,860 Market Cap: 385(M)

Technical analysis

as of: 2023-03-20 8:50:55 AM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 13.69     One year: 15.41
Support: Support1: 9.34    Support2: 7.77
Resistance: Resistance1: 11.72    Resistance2: 13.19
Pivot: 11.28
Moving Average: MA(5): 10.86     MA(20): 11.64
MA(100): 13.23     MA(250): 10.07
MACD: MACD(12,26): -0.8     Signal(9): -0.8
Stochastic oscillator: %K(14,3): 37.3     %D(3): 41.5
RSI: RSI(14): 35
52-week: High: 17.25  Low: 5.59
Average Vol(K): 3-Month: 282 (K)  10-Days: 430 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ZYXI ] has closed above bottom band by 34.6%. Bollinger Bands are 79.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 10.9 - 10.96 10.96 - 11.01
Low: 10.27 - 10.35 10.35 - 10.42
Close: 10.39 - 10.51 10.51 - 10.61

Company Description

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Headline News

Sat, 18 Mar 2023
ZYXI Investor Notice: ROSEN, Leading Investor Counsel, Encourages Zynex, Inc. Investors to Inquire About Class - EIN News

Fri, 17 Mar 2023
Is Zynex Inc. (ZYXI) the Top Pick in the Medical Distribution Industry? - InvestorsObserver

Wed, 15 Mar 2023
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims ... - Digital Journal

Wed, 15 Mar 2023
Zynex, Inc. (NASDAQ:ZYXI) Q4 2022 Earnings Call Transcript - Yahoo Finance

Tue, 14 Mar 2023
ROSEN, LEADING INVESTOR COUNSEL, Encourages Zynex, Inc ... - PR Newswire

Tue, 14 Mar 2023
Validea Peter Lynch Strategy Daily Upgrade Report - 3/14/2023 - Nasdaq

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Outperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Distribution
Shares Out. 37 (M)
Shares Float 20 (M)
% Held by Insiders 45.4 (%)
% Held by Institutions 29.5 (%)
Shares Short 4,150 (K)
Shares Short P.Month 3,430 (K)

Stock Financials

EPS 0.41
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.76
Profit Margin (%) 10.7
Operating Margin (%) 14.5
Return on Assets (ttm) 11.4
Return on Equity (ttm) 24.3
Qtrly Rev. Growth 20.8
Gross Profit (p.s.) 3.45
Sales Per Share 4.31
EBITDA (p.s.) 0.71
Qtrly Earnings Growth -13.2
Operating Cash Flow 14 (M)
Levered Free Cash Flow 8 (M)

Stock Valuations

PE Ratio 25
PEG Ratio 0
Price to Book value 5.93
Price to Sales 2.43
Price to Cash Flow 27.97

Stock Dividends

Dividend 0.1
Forward Dividend 0
Dividend Yield 0.9%
Dividend Pay Date 2022-01-20
Ex-Dividend Date 2022-01-04
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.